Published in Cancer Weekly, April 17th, 2006
According to a study from the United States, "The few studies that have estimated the costs of pancreatic cancer were limited by small sample sizes, geography or patient age range. Using a large nationwide claims database, this study examines the cost of pancreatic cancer beginning with initial diagnosis and the additional costs when disease progresses. A retrospective cohort study was conducted using a claims database of 3 million individuals covered by large US employers."
"The study population consisted of patients newly diagnosed with pancreatic cancer in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.